What is NDC 59651-251?

59651-251 is the product NDC for Nadolol, Nadolol 40 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nadolol?

52 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nadolol NDC 59651-251 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-251Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0251Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-251-01	5965102510159651025101	100 TABLET in 1 BOTTLE (59651-251-01)Marketed from Oct 29, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nadolol
Generic name (nonproprietary): nadolol
Active ingredients: Nadolol — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201893
Marketing start: Oct 29, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 59651-251_bfed393e-1baf-439a-8073-998c1a97b276SPL ID bfed393e-1baf-439a-8073-998c1a97b276SPL set ID 44c5352d-89f8-4bd3-9479-1069304562caRxCUI 198006, 198007, 198008UNII FEN504330V
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651025101 followed by a unit qualifier and the quantity

Package 59651-0251-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 10, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Angina Pectoris Nadolol tablets are indicated for the long-term management of patients with angina pectoris. Hypertension Nadolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with nadolol tablets. Control of high blood pressure should be part of comprehensive cardiov…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-251

What is NDC 59651-251?: 59651-251 is the product NDC for Nadolol, Nadolol 40 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nadolol.
What is the active ingredient?: Nadolol.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nadolol?: 52 other product NDCs are listed under this name. See all Nadolol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nadolol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Nadolol	Nadolol 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4662	70518-4662-00
Nadolol	Nadolol 20 mg/1	TabletOral	BluePoint Laboratories	68001-690	68001-0690-00
Nadolol	Nadolol 40 mg/1	TabletOral	BluePoint Laboratories	68001-691	68001-0691-00
Nadolol	Nadolol 80 mg/1	TabletOral	BluePoint Laboratories	68001-692	68001-0692-00
Nadolol	Nadolol 20 mg/1	TabletOral	American Health Packaging	60687-887	60687-0887-21
Nadolol	Nadolol 40 mg/1	TabletOral	American Health Packaging	60687-898	60687-0898-21
Nadolol	Nadolol 20 mg/1	TabletOral	BluePoint Laboratories	68001-630	68001-0630-00
Nadolol	Nadolol 40 mg/1	TabletOral	BluePoint Laboratories	68001-631	68001-0631-00
Nadolol	Nadolol 80 mg/1	TabletOral	BluePoint Laboratories	68001-632	68001-0632-00
Nadolol	Nadolol 20 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-402	46708-0402-3046708-0402-3146708-0402-91

All 53 Nadolol NDCs

Other NDCs under ANDA 201893

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201893
Product	Strength	Form · route	Labeler	Product NDC
Nadolol	Nadolol 80 mg/1	TabletOral	Aurobindo Pharma Limited	59651-252
Nadolol	Nadolol 20 mg/1	TabletOral	Aurobindo Pharma Limited	59651-589
Nadolol	Nadolol 20 mg/1	TabletOral	BluePoint Laboratories	68001-690
Nadolol	Nadolol 40 mg/1	TabletOral	BluePoint Laboratories	68001-691
Nadolol	Nadolol 80 mg/1	TabletOral	BluePoint Laboratories	68001-692
Nadolol	Nadolol 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4662